ulcerative colitis and tirzepatide Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases Obesity and/or Diabetes: A Target Trial Emulation Frontiers | Advancing therapeutic frontiers:

The increasing interest in GLP-1-boosting foods reflects a broader trend towards natural health solutions that complement modern medical advancements

Drug Metab Dispos

GLP-1R activation has a significant effect on glycemic control in patients with T2DM through a variety of mechanisms, including stimulation of insulin secretion, inhibition of glucagon secretion, protection of -cells from apoptosis, slowing gastric emptying and increasing satiety (Drucker, 2006)

2025 Jul;27(7):3607-3626

MiRNAs have unique characteristics (i.e

Cardiovascular Protection GLP-1s lower inflammation, improve endothelial function, and reduce cardiovascular eventsindependent of weight loss